Literature DB >> 1319256

Prevention of venous thromboembolism after surgery: a review of enoxaparin.

D Bergqvist1, G D Lowe, A Berstad, S Haas, J Hirsh, M R Lassen, M Samama, R Verhaeghe.   

Abstract

This review discusses the problem of deep vein thrombosis (DVT) after operation and identifies three levels of risk of DVT: low (less than 10 per cent), moderate (10-40 per cent) and high (40-80 per cent). Special emphasis is placed on the most recent prophylactic treatment, low molecular weight heparins (LMWHs), particularly enoxaparin. Several LMWHs are now available, but they differ slightly and each must be evaluated on its own merits. In general, however, LMWHs are both effective and safe in those patients at moderate or high risk of DVT. Thromboprophylaxis is cost effective when analysed using health-economic methodology.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319256     DOI: 10.1002/bjs.1800790607

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  2 in total

Review 1.  Enoxaparin. A reappraisal of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disease.

Authors:  S Noble; D H Peters; K L Goa
Journal:  Drugs       Date:  1995-03       Impact factor: 9.546

2.  Low molecular weight heparin in prophylaxis of deep vein thrombosis in Asian general surgical patients: A Kashmir experience.

Authors:  Tanveer Iqbal Dar; Khursheed Alam Wani; Mohd Ashraf; Aijaz Malik; Sanjeed Ahmad; Tariq A Gojwari; Arshad Iqbal
Journal:  Indian J Crit Care Med       Date:  2012-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.